Disorder of lipid absorption and transport

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309028
Who is this for?
Show terms as
5Active trials1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of lipid absorption and transport is a group of rare inherited conditions that affect how your body takes in fats (lipids) from food and moves them through the bloodstream. Lipids include cholesterol, triglycerides, and fatty acids, which are essential for energy, building cell membranes, and making hormones. In these disorders, the body either cannot properly absorb fats from the intestines or cannot package and transport them in the blood using special carrier proteins called lipoproteins. People with these conditions often experience problems starting in infancy or childhood, including chronic diarrhea, fatty or greasy stools (steatorrhea), poor weight gain, and failure to thrive. Because fat-soluble vitamins (A, D, E, and K) depend on fat absorption, deficiencies in these vitamins are common and can lead to serious complications such as vision problems, nerve damage, bone weakness, and bleeding disorders. Some forms of these disorders also cause very low cholesterol levels in the blood, fatty liver disease, and progressive neurological problems. Treatment focuses on managing symptoms and preventing complications. This typically includes a special low-fat diet supplemented with medium-chain triglycerides (MCTs), which are absorbed differently and can bypass the defective pathway. High-dose fat-soluble vitamin supplementation is critical to prevent or slow neurological and eye damage. With early diagnosis and consistent treatment, many patients can have improved outcomes, though lifelong management is usually required. The specific prognosis depends on which exact condition within this group a person has.

Key symptoms:

Chronic diarrheaFatty or greasy stoolsPoor weight gain and failure to thrive in infantsBloating and abdominal distensionFat-soluble vitamin deficiencies (vitamins A, D, E, K)Vision problems including night blindness and retinal degenerationNumbness or tingling in hands and feet (peripheral neuropathy)Difficulty with balance and coordination (ataxia)Muscle weaknessEasy bruising or prolonged bleedingFatty liver (hepatic steatosis)Very low cholesterol levels in the bloodGrowth delays in childrenAnemia with abnormally shaped red blood cells (acanthocytosis)

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Dec 2025A Study of DII235 in Adults With Elevated Lipoprotein(a)

Novartis Pharmaceuticals — PHASE2

TrialRECRUITING
Oct 2025Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Kylonova (Xiamen) Biopharma co., LTD. — PHASE2

TrialRECRUITING
Oct 2025A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Fujian Shengdi Pharmaceutical Co., Ltd. — PHASE2

TrialACTIVE NOT RECRUITING
Sep 2024The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation

University of Athens

TrialRECRUITING
May 2019Extreme Lipids Repository

University of Texas Southwestern Medical Center

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Disorder of lipid absorption and transport.

5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

5 recruitingView all trials with filters →
Phase 23 trials
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Phase 2
Actively Recruiting
· Sites: Beijing, Beijing Municipality; Baotou +41 more · Age: 1880 yrs
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
Phase 2
Active
· Sites: Xi’an, Shanxi; Xi’an, Shanxi · Age: 1899 yrs
A Study of DII235 in Adults With Elevated Lipoprotein(a)
Phase 2
Actively Recruiting
PI: Novartis Pharmaceuticals (Novartis Pharmaceuticals) · Sites: Birmingham, Alabama; Huntsville, Alabama +58 more · Age: 1880 yrs
Other2 trials
The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation
Actively Recruiting
PI: Ignatios Ikonomidis (National and Kapodistrian University of Athens) · Sites: Athens, Attica; Athens, Rimini 1 · Age: 1875 yrs
Extreme Lipids Repository
Active
PI: Anand Rohatgi, MD (University of Texas Southwestern Medical Center) · Sites: Dallas, Texas; Dallas, Texas · Age: 1899 yrs

Specialists

1 foundView all specialists →
RM
Richard E Ostlund, MD
SAINT LOUIS, MO
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of lipid absorption and transport.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of lipid absorption and transportForum →

No community posts yet. Be the first to share your experience with Disorder of lipid absorption and transport.

Start the conversation →

Latest news about Disorder of lipid absorption and transport

No recent news articles for Disorder of lipid absorption and transport.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific type of lipid absorption disorder does my child (or I) have, and which gene is affected?,What are the target blood levels for fat-soluble vitamins, and how often should they be checked?,What specific doses of vitamins A, D, E, and K should be taken, and in what form?,How much fat is safe to eat, and should I work with a specialized dietitian?,What neurological and eye complications should I watch for, and how often should screening happen?,Are there any clinical trials or new treatments being studied for this condition?,Should other family members be tested, and what is the chance of passing this to future children?

Common questions about Disorder of lipid absorption and transport

What is Disorder of lipid absorption and transport?

Disorder of lipid absorption and transport is a group of rare inherited conditions that affect how your body takes in fats (lipids) from food and moves them through the bloodstream. Lipids include cholesterol, triglycerides, and fatty acids, which are essential for energy, building cell membranes, and making hormones. In these disorders, the body either cannot properly absorb fats from the intestines or cannot package and transport them in the blood using special carrier proteins called lipoproteins. People with these conditions often experience problems starting in infancy or childhood, incl

Are there clinical trials for Disorder of lipid absorption and transport?

Yes — 5 recruiting clinical trials are currently listed for Disorder of lipid absorption and transport on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Disorder of lipid absorption and transport?

1 specialists and care centers treating Disorder of lipid absorption and transport are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.